• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   MD(e)B(unker)  
Title Created Date
Why you should not use the journal impact factor to evaluate research 12 January 2014
Declaration recommends eliminate the use of Impact factor for research evaluation 10 January 2014
Display # 

Search

Follow us...

Latest

  • Melatonin combats molecular terrorism at the mitochondrial level
  • Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells
  • Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions
  • Beta-carotene prolongs survival, decreases lipid peroxidation and enhances glutathione status in transplantable murine lymphoma
  • Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo
  • Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent
  • Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis
  • Somatostatin and somatostatin receptor physiology
  • Novel function of ascorbic acid as an angiostatic factor
  • An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta
  • From somatostatin to octreotide LAR: evolution of a somatostatin analogue
  • A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness
  • Vitamin D food fortification in European countries: the underused potential to prevent cancer deaths
  • Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
  • Induction of leukotriene C4 synthase after the differentiation of rat basophilic leukemia cells with retinoic acid and a low dose of actinomycin D and its suppression with methylprednisolone
  • Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer
  • Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo
  • Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Bibliography
  • Somatostatin in oncology, the overlooked evidences
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • How effective is chemo therapy?
  • Frequently Asked Questions
  • Vademecum
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
  • The melatonin deception